# Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

> **NCT06435351** · EARLY_PHASE1 · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 16 (estimated)

## Conditions studied

- Breast Cancer
- Triple Negative Breast Cancer

## Interventions

- **PROCEDURE:** Leukapheresis
- **BIOLOGICAL:** Dendritic Cell (DC) Vaccine

## Key facts

- **NCT ID:** NCT06435351
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-12
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06435351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06435351, "Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06435351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*